Prospersim personal page - To The Moon

Prospersim

Prospersim

No personal profile

8Follow

0Followers

0Topic

0Badge

2021-06-18

Nice!

NIO Is Winning

2021-06-16

Ok

Sorry, the original content has been removed

2021-06-15

Ok

Sorry, the original content has been removed

2021-06-15

Great

Sorry, the original content has been removed

2021-03-24

Hmmm

Sorry, the original content has been removed

2021-03-24

Nice

Sorry, the original content has been removed

2021-03-18

Interesting

U.N. body raises global economic growth forecast for 2021 to 4.7%

2021-03-18

Interesting

Sorry, the original content has been removed

2021-03-17

Good info

The S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says

2021-03-17

Wow

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3578379695086113,"uuid":"3578379695086113","gmtCreate":1615285769386,"gmtModify":1615947840846,"name":"Prospersim","pinyin":"prospersim","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":166246367,"gmtCreate":1624014430459,"gmtModify":1703826570316,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166246367","repostId":"1148576248","repostType":4,"repost":{"id":"1148576248","pubTimestamp":1623979883,"share":"https://www.laohu8.com/m/news/1148576248?lang=&edition=full","pubTime":"2021-06-18 09:31","market":"us","language":"en","title":"NIO Is Winning","url":"https://stock-news.laohu8.com/highlight/detail?id=1148576248","media":"seekingalpha","summary":"NIO is #1 in China's electric SUV market for good reason.The company's success is driven by its brilliant innovations and marketing strategy.NIO is growing faster than Tesla, and yet, it is trading at a discount.NIO Inc.  stands out for its strong market position- #1 market share in electric SUV in China- and innovation in the rapidly growing and highly competitive electric vehicle industry. This article will discuss why NIO is winning against some stiff competition, including against Tesla .In ","content":"<p><b>Summary</b></p>\n<ul>\n <li>NIO is #1 in China's electric SUV market for good reason.</li>\n <li>The company's success is driven by its brilliant innovations and marketing strategy.</li>\n <li>NIO is growing faster than Tesla, and yet, it is trading at a discount.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/790fae23b830463fec748d2deb2ce336\" tg-width=\"1536\" tg-height=\"1024\" referrerpolicy=\"no-referrer\"><span>PonyWang/E+ via Getty Images</span></p>\n<p>NIO Inc. (NYSE:NIO) stands out for its strong market position- #1 market share in electric SUV in China- and innovation in the rapidly growing and highly competitive electric vehicle industry. This article will discuss why NIO is winning against some stiff competition, including against Tesla (TSLA).</p>\n<p>In addition, we will discuss NIO's business, financials, trading, valuation, and risks so readers could reach their own informed decision.</p>\n<p><b>Business: Why NIO Wins</b></p>\n<p>NIO positions itself in the premium SUV segment, focusing on smart EVs with a differentiated battery strategy.</p>\n<p>Delivered in March 2019, the company's first model, the ES8, is a luxury 7-seater SUV that is still the company's flagship product today. The ES8 is equipped with ADAS and AI system [NOMI] and is comparable to the BYD Song, Tesla Model X, the Audi Q7 45 e-Tron, etc.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/443e2773f70c00c6faac8ca063e978a5\" tg-width=\"640\" tg-height=\"387\" referrerpolicy=\"no-referrer\"><span>Source: Company</span></p>\n<p>Leveraging the installed base and customer goodwill due to the highly successful ES8, NIO successfully launched the ES6 and EC6.Recently, the company launched the ET7, its first sedan.</p>\n<p>Today, NIO is the top-selling brand in China's all-electric SUV market in April with a 23% market share, higher than Tesla's 17%, WM Motor and XPeng Motors'(NYSE:XPEV)7%, according to China Automotive Technology and Research Center data.</p>\n<p>One of the biggest competitive differentiators is NIO'sbattery strategy, which all but eliminates range anxiety, one of the biggest barriers to mass EV adoption. Not only could NIO cars be charged at any charging station for EVs, but the company also built hundreds of battery swapping stations in key cities in China, with plans to expanding to Europe.</p>\n<p>NIO's battery swapping strategy also gives the company the ability to offer a battery-as-a-service [BaaS] solution, which reduces the upfrontcostof purchasing an NIO vehicle by ~$11,000. Since cost is another major barrier to mass EV adoption, NIO's battery strategy appears brilliant as it solves both the range and cost problems.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5b25fbb85bffd39310cd27cbb2bde57a\" tg-width=\"640\" tg-height=\"216\" referrerpolicy=\"no-referrer\"><span>Source: Company</span></p>\n<p>Another differentiator is the NIO brand, which management created brilliantly by introducing the EP9 in 2016. Six EP9s have been sold to NIO investors for 2.5 million pounds, creating an aura of exclusivity and quality around the brand. Next, NIO targeted the mass-market luxury SUV segment with the ES8, firmly establishing the company as a luxury car OEM.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ad41c960ce02f1e3f3e7575ac00beee0\" tg-width=\"640\" tg-height=\"350\" referrerpolicy=\"no-referrer\"><span>Source: Company</span></p>\n<p>Chinese companies must struggle against the common perception that they make low-quality products. This is the same perception issue that Japanese companies faced following their defeat after WW2. Japan solved this problem by moving up the value chain as their economy matured and creating high-quality brands such as Sony(NYSE:SONY). Today, Japan is known for its craftsmanship.</p>\n<p>China is following the same trajectory, and NIO is one of the emerging brands destroying the perception that \"made in China\" equates to poor quality. I strongly believe that investors who stubbornly hold on to that old perception will miss out on investing in some of the greatest brands the world will ever see.</p>\n<p>Buying an NIO car means much more than just getting a vehicle; it means getting into an exclusive club of services and convenience. Benefits include access to hundreds of swapping stations, lifetime free roadside rescue (including charge vans), lifetime free cellular connectivity, lifetime free warranty, and excellent customer service. This is a powerful selling point for NIO, differentiating it from Tesla, which hasrecentlydeveloped a poor reputation on the customer service front in China.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a73482aa0431694b760ab5c2d0aa6f53\" tg-width=\"640\" tg-height=\"211\" referrerpolicy=\"no-referrer\"><span>Source: Company</span></p>\n<p>The company is pushing the envelope even further with&nbsp;NIO House, a literal clubhouse for customers, and&nbsp;NIO Life, which includes NIO branded lifestyle products. NIO's effort to build a lifestyle around its cars seems to be&nbsp;working. This is good news for investors because the only way to escape the competitive battlefield of automobile OEM is to sell services and lifestyles to customers. This is why Ferrari's (RACE) operating margin is well over 20%, while Ford (F) and General Motors (GM) are in the single digits.</p>\n<p><b>Financials &amp; Valuation</b></p>\n<p>NIO is in hyper-growth mode. In 2020, the company generated $2.5 billion in revenue, up 126% y/y. In 2021, the company is expected to grow 117% y/y to $5.4 billion.</p>\n<p>The company is not yet profitable but is expected to be by 2022. Gross margin only turned positive in 2020 and is expected to be 19.3% in 2021. EBITDA is expected to be negative $258 million in 2021 and a positive $206 million in 2022. Free cash flow is expected to be negative $42 million in 2021 before turning to a positive $354 million in 2022.</p>\n<p>However, despite the cash burn expected in 2021, investors should feel at ease since the company exited&nbsp;2020&nbsp;with $5.9 billion of cash and cash equivalents. Including $600 million in short-term investments and subtracting ~$2.1 billion in debt and operating leases and the expected negative free cash flow in 2021, NIO should exit 2021 with over $4 billion in net cash and investments. That is plenty of buffers since NIO is expected to generate positive free cash flow in 2022.</p>\n<p>Since NIO is not yet profitable, we will look at the forward EV/Sales multiple as is typical for hyper-growth companies not yet generating a profit. The company went public in September 2018, trading at around 7 to 8 times EV/Sales, before bottoming out at around 0.7 times sales in May 2019. The market, however, caught the EV fever in April 2020 and sent NIO's valuation soaring to a peak of 14.6x by January 2021. After the growth sell-off we recently experienced, NIO is currently sitting at a much more reasonable 8 times forward sales. This is a significant discount to TSLA's 10.2 times forward EV/Sales despite growing twice as fast (TSLA is expected to grow revenues by 57% in 2021 compared to NIO's 117%).</p>\n<p><b>Risks</b></p>\n<p>There are many risks associated with owning NIO.</p>\n<p>Although its battery swapping strategy is highly differentiated and seems to be growing rapidly, the jury is still out on the ultimate market share of battery swapping or fast-charging infrastructure. If fast charging technology continues to advance significantly, it will likely erode a key advantage of battery swapping: speed.</p>\n<p>NIO's business model is innovative and new. Unfortunately, the flip side of that is that it is untested, and NIO remains unprofitable. For many investors, NIO will remain a \"show me\" story until the profitability of its business model improves.</p>\n<p>NIO's ability to expand globally may be limited by the rising geopolitical tension between China and the US, and to a lesser extent, with Japan and Europe. The geopolitical situation remains highly opaque and uncertain, and is a risk factor for all auto OEMs.</p>\n<p>Auto OEMs are currently facing a severe chip&nbsp;shortage. In addition, the chip density in automobiles is increasing, making the OEMs increasingly reliant on semiconductor suppliers and foundries.</p>\n<p>NIO's competitive advantages may not overcome the massive scale advantage of ICE OEMs and much bigger EV players like Tesla and China's BYD.</p>\n<p><b>Takeaway</b></p>\n<p>NIO's technical and business model innovations make it a highly differentiated company in the exciting and rapidly growing EV market. The company is winning, and its competitive moat is getting bigger as its ecosystem of vehicles and services grows. Relative to the industry leader, Tesla, NIO's stock price seems like a bargain given its faster growth rate and lower multiples.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Is Winning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Is Winning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 09:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435341-nio-is-winning><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nNIO is #1 in China's electric SUV market for good reason.\nThe company's success is driven by its brilliant innovations and marketing strategy.\nNIO is growing faster than Tesla, and yet, it is...</p>\n\n<a href=\"https://seekingalpha.com/article/4435341-nio-is-winning\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://seekingalpha.com/article/4435341-nio-is-winning","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148576248","content_text":"Summary\n\nNIO is #1 in China's electric SUV market for good reason.\nThe company's success is driven by its brilliant innovations and marketing strategy.\nNIO is growing faster than Tesla, and yet, it is trading at a discount.\n\nPonyWang/E+ via Getty Images\nNIO Inc. (NYSE:NIO) stands out for its strong market position- #1 market share in electric SUV in China- and innovation in the rapidly growing and highly competitive electric vehicle industry. This article will discuss why NIO is winning against some stiff competition, including against Tesla (TSLA).\nIn addition, we will discuss NIO's business, financials, trading, valuation, and risks so readers could reach their own informed decision.\nBusiness: Why NIO Wins\nNIO positions itself in the premium SUV segment, focusing on smart EVs with a differentiated battery strategy.\nDelivered in March 2019, the company's first model, the ES8, is a luxury 7-seater SUV that is still the company's flagship product today. The ES8 is equipped with ADAS and AI system [NOMI] and is comparable to the BYD Song, Tesla Model X, the Audi Q7 45 e-Tron, etc.\nSource: Company\nLeveraging the installed base and customer goodwill due to the highly successful ES8, NIO successfully launched the ES6 and EC6.Recently, the company launched the ET7, its first sedan.\nToday, NIO is the top-selling brand in China's all-electric SUV market in April with a 23% market share, higher than Tesla's 17%, WM Motor and XPeng Motors'(NYSE:XPEV)7%, according to China Automotive Technology and Research Center data.\nOne of the biggest competitive differentiators is NIO'sbattery strategy, which all but eliminates range anxiety, one of the biggest barriers to mass EV adoption. Not only could NIO cars be charged at any charging station for EVs, but the company also built hundreds of battery swapping stations in key cities in China, with plans to expanding to Europe.\nNIO's battery swapping strategy also gives the company the ability to offer a battery-as-a-service [BaaS] solution, which reduces the upfrontcostof purchasing an NIO vehicle by ~$11,000. Since cost is another major barrier to mass EV adoption, NIO's battery strategy appears brilliant as it solves both the range and cost problems.\nSource: Company\nAnother differentiator is the NIO brand, which management created brilliantly by introducing the EP9 in 2016. Six EP9s have been sold to NIO investors for 2.5 million pounds, creating an aura of exclusivity and quality around the brand. Next, NIO targeted the mass-market luxury SUV segment with the ES8, firmly establishing the company as a luxury car OEM.\nSource: Company\nChinese companies must struggle against the common perception that they make low-quality products. This is the same perception issue that Japanese companies faced following their defeat after WW2. Japan solved this problem by moving up the value chain as their economy matured and creating high-quality brands such as Sony(NYSE:SONY). Today, Japan is known for its craftsmanship.\nChina is following the same trajectory, and NIO is one of the emerging brands destroying the perception that \"made in China\" equates to poor quality. I strongly believe that investors who stubbornly hold on to that old perception will miss out on investing in some of the greatest brands the world will ever see.\nBuying an NIO car means much more than just getting a vehicle; it means getting into an exclusive club of services and convenience. Benefits include access to hundreds of swapping stations, lifetime free roadside rescue (including charge vans), lifetime free cellular connectivity, lifetime free warranty, and excellent customer service. This is a powerful selling point for NIO, differentiating it from Tesla, which hasrecentlydeveloped a poor reputation on the customer service front in China.\nSource: Company\nThe company is pushing the envelope even further with NIO House, a literal clubhouse for customers, and NIO Life, which includes NIO branded lifestyle products. NIO's effort to build a lifestyle around its cars seems to be working. This is good news for investors because the only way to escape the competitive battlefield of automobile OEM is to sell services and lifestyles to customers. This is why Ferrari's (RACE) operating margin is well over 20%, while Ford (F) and General Motors (GM) are in the single digits.\nFinancials & Valuation\nNIO is in hyper-growth mode. In 2020, the company generated $2.5 billion in revenue, up 126% y/y. In 2021, the company is expected to grow 117% y/y to $5.4 billion.\nThe company is not yet profitable but is expected to be by 2022. Gross margin only turned positive in 2020 and is expected to be 19.3% in 2021. EBITDA is expected to be negative $258 million in 2021 and a positive $206 million in 2022. Free cash flow is expected to be negative $42 million in 2021 before turning to a positive $354 million in 2022.\nHowever, despite the cash burn expected in 2021, investors should feel at ease since the company exited 2020 with $5.9 billion of cash and cash equivalents. Including $600 million in short-term investments and subtracting ~$2.1 billion in debt and operating leases and the expected negative free cash flow in 2021, NIO should exit 2021 with over $4 billion in net cash and investments. That is plenty of buffers since NIO is expected to generate positive free cash flow in 2022.\nSince NIO is not yet profitable, we will look at the forward EV/Sales multiple as is typical for hyper-growth companies not yet generating a profit. The company went public in September 2018, trading at around 7 to 8 times EV/Sales, before bottoming out at around 0.7 times sales in May 2019. The market, however, caught the EV fever in April 2020 and sent NIO's valuation soaring to a peak of 14.6x by January 2021. After the growth sell-off we recently experienced, NIO is currently sitting at a much more reasonable 8 times forward sales. This is a significant discount to TSLA's 10.2 times forward EV/Sales despite growing twice as fast (TSLA is expected to grow revenues by 57% in 2021 compared to NIO's 117%).\nRisks\nThere are many risks associated with owning NIO.\nAlthough its battery swapping strategy is highly differentiated and seems to be growing rapidly, the jury is still out on the ultimate market share of battery swapping or fast-charging infrastructure. If fast charging technology continues to advance significantly, it will likely erode a key advantage of battery swapping: speed.\nNIO's business model is innovative and new. Unfortunately, the flip side of that is that it is untested, and NIO remains unprofitable. For many investors, NIO will remain a \"show me\" story until the profitability of its business model improves.\nNIO's ability to expand globally may be limited by the rising geopolitical tension between China and the US, and to a lesser extent, with Japan and Europe. The geopolitical situation remains highly opaque and uncertain, and is a risk factor for all auto OEMs.\nAuto OEMs are currently facing a severe chip shortage. In addition, the chip density in automobiles is increasing, making the OEMs increasingly reliant on semiconductor suppliers and foundries.\nNIO's competitive advantages may not overcome the massive scale advantage of ICE OEMs and much bigger EV players like Tesla and China's BYD.\nTakeaway\nNIO's technical and business model innovations make it a highly differentiated company in the exciting and rapidly growing EV market. The company is winning, and its competitive moat is getting bigger as its ecosystem of vehicles and services grows. Relative to the industry leader, Tesla, NIO's stock price seems like a bargain given its faster growth rate and lower multiples.","news_type":1},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169649031,"gmtCreate":1623834699623,"gmtModify":1703820869276,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169649031","repostId":"1126302775","repostType":4,"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160316118,"gmtCreate":1623772172034,"gmtModify":1703819026950,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160316118","repostId":"1150591447","repostType":4,"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160318702,"gmtCreate":1623772160106,"gmtModify":1703819026465,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160318702","repostId":"1187337744","repostType":4,"isVote":1,"tweetType":1,"viewCount":45,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351800139,"gmtCreate":1616579995521,"gmtModify":1704795922758,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351800139","repostId":"1178385748","repostType":4,"isVote":1,"tweetType":1,"viewCount":153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351177941,"gmtCreate":1616579934583,"gmtModify":1704795920637,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351177941","repostId":"1169987647","repostType":4,"isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327928699,"gmtCreate":1616052699111,"gmtModify":1704790244087,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327928699","repostId":"2120130261","repostType":4,"repost":{"id":"2120130261","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1616048501,"share":"https://www.laohu8.com/m/news/2120130261?lang=&edition=full","pubTime":"2021-03-18 14:21","market":"hk","language":"en","title":"U.N. body raises global economic growth forecast for 2021 to 4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2120130261","media":"Reuters","summary":"GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronge","content":"<p>GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronger-than-expected recovery in the United States, a report by the U.N. Conference on Trade and Development (UNCTAD) said on Thursday, revising up its previous forecast of 4.3%.</p>\n<p>The upwards revision from its previous forecast made last September factors in an expected boost in U.S. consumer spending on the back of progress distributing COVID-19 vaccines and a vast stimulus package, the report said.</p>\n<p>\"The global recovery that began in the third quarter of 2020 is expected to continue through 2021, albeit with a good deal of unevenness and unpredictability, reflecting epidemiological, policy and coordination uncertainties,\" the report said.</p>\n<p>Earlier this month, the OECD also revised higher its growth forecast for this year to 5.6 % from 4.2 %.</p>\n<p>However, the 22-page UNCTAD report called 'Out of the frying pan...into the fire?' said COVID-19 will have lasting economic consequences that will require continued government support. It said the main risk to the global outlook is a \"misguided return to austerity\".</p>\n<p>The report estimates that last year there was a 3.9 % drop in output as the spread of the coronavirus sparked lockdowns across the world.</p>\n<p>It called the impact \"exorbitant\", describing the \"destruction of income on an unprecedented scale\" with people in developing countries particularly hard hit.</p>\n<p>Still, it says it would have been worse had central banks not taken preemptive action to avoid financial meltdown. Relief packages and a bounce-back in commodity prices as well as the fast-tracking of vaccine development also helped, the report said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.N. body raises global economic growth forecast for 2021 to 4.7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.N. body raises global economic growth forecast for 2021 to 4.7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-18 14:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronger-than-expected recovery in the United States, a report by the U.N. Conference on Trade and Development (UNCTAD) said on Thursday, revising up its previous forecast of 4.3%.</p>\n<p>The upwards revision from its previous forecast made last September factors in an expected boost in U.S. consumer spending on the back of progress distributing COVID-19 vaccines and a vast stimulus package, the report said.</p>\n<p>\"The global recovery that began in the third quarter of 2020 is expected to continue through 2021, albeit with a good deal of unevenness and unpredictability, reflecting epidemiological, policy and coordination uncertainties,\" the report said.</p>\n<p>Earlier this month, the OECD also revised higher its growth forecast for this year to 5.6 % from 4.2 %.</p>\n<p>However, the 22-page UNCTAD report called 'Out of the frying pan...into the fire?' said COVID-19 will have lasting economic consequences that will require continued government support. It said the main risk to the global outlook is a \"misguided return to austerity\".</p>\n<p>The report estimates that last year there was a 3.9 % drop in output as the spread of the coronavirus sparked lockdowns across the world.</p>\n<p>It called the impact \"exorbitant\", describing the \"destruction of income on an unprecedented scale\" with people in developing countries particularly hard hit.</p>\n<p>Still, it says it would have been worse had central banks not taken preemptive action to avoid financial meltdown. Relief packages and a bounce-back in commodity prices as well as the fast-tracking of vaccine development also helped, the report said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2120130261","content_text":"GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronger-than-expected recovery in the United States, a report by the U.N. Conference on Trade and Development (UNCTAD) said on Thursday, revising up its previous forecast of 4.3%.\nThe upwards revision from its previous forecast made last September factors in an expected boost in U.S. consumer spending on the back of progress distributing COVID-19 vaccines and a vast stimulus package, the report said.\n\"The global recovery that began in the third quarter of 2020 is expected to continue through 2021, albeit with a good deal of unevenness and unpredictability, reflecting epidemiological, policy and coordination uncertainties,\" the report said.\nEarlier this month, the OECD also revised higher its growth forecast for this year to 5.6 % from 4.2 %.\nHowever, the 22-page UNCTAD report called 'Out of the frying pan...into the fire?' said COVID-19 will have lasting economic consequences that will require continued government support. It said the main risk to the global outlook is a \"misguided return to austerity\".\nThe report estimates that last year there was a 3.9 % drop in output as the spread of the coronavirus sparked lockdowns across the world.\nIt called the impact \"exorbitant\", describing the \"destruction of income on an unprecedented scale\" with people in developing countries particularly hard hit.\nStill, it says it would have been worse had central banks not taken preemptive action to avoid financial meltdown. Relief packages and a bounce-back in commodity prices as well as the fast-tracking of vaccine development also helped, the report said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327928306,"gmtCreate":1616052647105,"gmtModify":1704790243601,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327928306","repostId":"2120518003","repostType":4,"isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324320857,"gmtCreate":1615966709279,"gmtModify":1704789021336,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/324320857","repostId":"1180242005","repostType":4,"repost":{"id":"1180242005","pubTimestamp":1615966420,"share":"https://www.laohu8.com/m/news/1180242005?lang=&edition=full","pubTime":"2021-03-17 15:33","market":"us","language":"en","title":"The S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says","url":"https://stock-news.laohu8.com/highlight/detail?id=1180242005","media":"Business Insider","summary":"The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.","content":"<ul>\n <li><b>The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.</b></li>\n <li><b>The bank pointed to strong seasonality and a developing cup and handle pattern that generates a 4,270 price target on the S&amp;P 500.</b></li>\n <li><b>\"Seasonality shines in April, which is the strongest month of the November to April period and is up 66% of the time,\" BofA said.</b></li>\n</ul>\n<p>Record highs in the stock market will continue to be made over the next few weeks if a Tuesday note from Bank of America pans out.</p>\n<p>The bank expects the S&amp;P 500 to hit a 4,270 price target derived from&nbsp;a bullish cup and handle pattern, which represents potential upside of 8% from Monday's close.</p>\n<p>And it's a bullish backdrop for stocks to continue their uptrend based on seasonality data, as April is the strongest month of the best 6-month period of the year, according to the note.</p>\n<p>\"Seasonality shines in April, which is the strongest month of the November-April period and is up 66% of the time with an average return of 1.37%,\" BofA said. The bank's seasonality analysis is based on data going back to 1928.</p>\n<p>On top of that, April is the second best month behind July in terms of average return, and the second best month behind December in terms of the percentage of time up, according to BofA.</p>\n<p>From a technical perspective, BofA highlights big picture levels on the S&amp;P 500, based on a bullish cup and handle pattern formed last year. A cup and handle often resembles a cup, formed by a basing pattern that typically looks like a \"U,\" followed by a handle that is formed by a short-term down trend. This pattern usually extends an uptrend that is already in place.</p>\n<p>BofA's 4,270 price target on the S&amp;P 500 is based on a measured move of the depth of the cup formed in March of 2020 and the eventual breakout later in July.</p>\n<p>Also favoring continued upside for the S&amp;P 500 is new highs in Advance/Decline line, which indicates that underlying market breadth is strong. The Advance/Decline line measures the difference of stocks that are moving higher or lower on a daily basis.</p>\n<p>\"A bullish A-D line sets up the S&amp;P 500 for a breakout above 3,950 - 3,960 that would favor upside to 4,065 next with the 2020 cup and handle target at 4,270,\" BofA said.</p>\n<p>And if the S&amp;P 500 does falter, investors should look to big picture support levels at 3,700, 3,550, and 3,200, BofA highlighted.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b5e8c7f39d815d6d80277066e3cc5145\" tg-width=\"790\" tg-height=\"442\"><span>Bank of America</span></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-17 15:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/stock-market-outlook-sp500-to-strong-seasonality-bullish-technicals-bofa-2021-3-1030216115><strong>Business Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.\nThe bank pointed to strong seasonality and a developing cup and handle pattern that generates a 4,...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/stock-market-outlook-sp500-to-strong-seasonality-bullish-technicals-bofa-2021-3-1030216115\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://markets.businessinsider.com/news/stocks/stock-market-outlook-sp500-to-strong-seasonality-bullish-technicals-bofa-2021-3-1030216115","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180242005","content_text":"The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.\nThe bank pointed to strong seasonality and a developing cup and handle pattern that generates a 4,270 price target on the S&P 500.\n\"Seasonality shines in April, which is the strongest month of the November to April period and is up 66% of the time,\" BofA said.\n\nRecord highs in the stock market will continue to be made over the next few weeks if a Tuesday note from Bank of America pans out.\nThe bank expects the S&P 500 to hit a 4,270 price target derived from a bullish cup and handle pattern, which represents potential upside of 8% from Monday's close.\nAnd it's a bullish backdrop for stocks to continue their uptrend based on seasonality data, as April is the strongest month of the best 6-month period of the year, according to the note.\n\"Seasonality shines in April, which is the strongest month of the November-April period and is up 66% of the time with an average return of 1.37%,\" BofA said. The bank's seasonality analysis is based on data going back to 1928.\nOn top of that, April is the second best month behind July in terms of average return, and the second best month behind December in terms of the percentage of time up, according to BofA.\nFrom a technical perspective, BofA highlights big picture levels on the S&P 500, based on a bullish cup and handle pattern formed last year. A cup and handle often resembles a cup, formed by a basing pattern that typically looks like a \"U,\" followed by a handle that is formed by a short-term down trend. This pattern usually extends an uptrend that is already in place.\nBofA's 4,270 price target on the S&P 500 is based on a measured move of the depth of the cup formed in March of 2020 and the eventual breakout later in July.\nAlso favoring continued upside for the S&P 500 is new highs in Advance/Decline line, which indicates that underlying market breadth is strong. The Advance/Decline line measures the difference of stocks that are moving higher or lower on a daily basis.\n\"A bullish A-D line sets up the S&P 500 for a breakout above 3,950 - 3,960 that would favor upside to 4,065 next with the 2020 cup and handle target at 4,270,\" BofA said.\nAnd if the S&P 500 does falter, investors should look to big picture support levels at 3,700, 3,550, and 3,200, BofA highlighted.\nBank of America","news_type":1},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325469184,"gmtCreate":1615914546248,"gmtModify":1704788477085,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325469184","repostId":"1121564086","repostType":4,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":166246367,"gmtCreate":1624014430459,"gmtModify":1703826570316,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166246367","repostId":"1148576248","repostType":4,"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351177941,"gmtCreate":1616579934583,"gmtModify":1704795920637,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351177941","repostId":"1169987647","repostType":4,"isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169649031,"gmtCreate":1623834699623,"gmtModify":1703820869276,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/169649031","repostId":"1126302775","repostType":4,"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327928306,"gmtCreate":1616052647105,"gmtModify":1704790243601,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327928306","repostId":"2120518003","repostType":4,"repost":{"id":"2120518003","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1616048919,"share":"https://www.laohu8.com/m/news/2120518003?lang=&edition=full","pubTime":"2021-03-18 14:28","market":"us","language":"en","title":"3 Biotech Stocks That Could Double In 12 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2120518003","media":"Benzinga","summary":"Biotech stocks are risky investment bets that can swing an investor's fortunes in a big way. An inve","content":"<p><img src=\"https://static.tigerbbs.com/99883de80af9932feab97ad0486ef6d3\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p>Biotech stocks are risky investment bets that can swing an investor's fortunes in a big way. An investment decision backed by careful scrutiny and analysis&nbsp;— of a company's&nbsp;pipeline, collaborations, fundamentals, key make-or-break events and cash runway&nbsp;— can fetch disproportionate returns.</p>\n<p>Here are three biopharma stocks that have the potential to more than double from current levels:</p>\n<ul>\n <li><b>Immatics </b>(NASDAQ: IMTX)</li>\n <li><b><a href=\"https://laohu8.com/S/FGEN\">FibroGen, Inc</a>. </b>(NASDAQ: FGEN)</li>\n <li><b>Replimune Group, Inc. </b>(NASDAQ: REPL)</li>\n <li><b>Immatics: </b> Immatics is a clinical-stage biopharma engaged in the discovery and development of T cell directing cancer immunotherapies.</li>\n</ul>\n<p>The shares of the German biotech were listed on the Nasdaq in July 2020 following its business combination with Arya Sciences Acquisition Corp, a SPAC sponsored by Perceptive Advisors.</p>\n<p><b>The Pipeline: </b> The company's T cell receptor (TCR)-based&nbsp;immunotherapies offer a targeted therapy to patients with high medical need. It has two lead product classes, namely engineered Adoptive Cell Therapies, or ACTengine, and antibody-like TCR Bispecifics, or TCER.</p>\n<p>ACTengine is based on genetically engineering patients own T cells —&nbsp;a type of blood cells that are key to the immune system —&nbsp;with a TCR to recognize the cancer target. This would program the T cells to attack the tumor. These engineered T cells are then multiplied in labs and reinfused into the patients to treat the tumor.</p>\n<p>The product candidates belonging to the class ACT are IMA201, IMA 202 and IMA203, which are in Phase 1 trials, as well as IMA204, which is in preclinical development. IMA301 is preclinical stage ACT allo product candidate.</p>\n<p>IMA401 and IMA402 are two preclinical TCR bispecifics candidates.</p>\n<p>The company has a string of partnerships with large biopharma companies such as <b>Amgen Inc. </b>(NASDAQ: AMGN), <b>Bristol-Myers Squibb Company </b>(NYSE: BMY) and <b>GlaxoSmithKline plc </b>(NYSE: GSK).</p>\n<p>\"Overall, we view TCR approaches as potentially transformational for the solid tumor therapeutic space, with the ability to target a wide range of antigens not accessible by CAR-T or classical antibody approaches,\" SVB Leerink analyst Jonathan Chang said in a note.</p>\n<p>Although competition is steadily increasing, Immatics' comprehensive TCR-based immunotherapy approach will expand the potential utilization of TCRs across a broad range of tumor types and stages, the analyst said.</p>\n<p>Cash and cash equivalents as well as other financial assets stood at $303.6 million&nbsp;as of Sept, 30, 2020, providing cash runway into 2023.</p>\n<p><b>Upcoming Catalysts: </b>Combined initial data readout from its ACTengine product candidates,&nbsp;IMA201 and IMA 202,&nbsp;in solid tumors and IMA203 in hematologic malignancies and solid cancers in the first quarter.</p>\n<p>Investigational new drug application filing for IMA204 in solid cancers in 2021.</p>\n<p>IND filing for IMA301 in hematological and solid cancers in 2022.</p>\n<p>IND filing for IMA-401 in solid cancers by year end 2022.</p>\n<p><b>FibroGen: </b> FibroGen focuses on advancing treatment options for anemia, fibrotic disease and cancer, leveraging its expertise in fibrosis and hypoxia-inducible factor biology.</p>\n<p>HIF is a protein complex that plays a key role in the body's response to low oxygen concentrations and inflammation.</p>\n<p><b>The Pipeline: </b> FibroGen's anemia drug roxadustat is being developed along with <b>AstraZeneca <a href=\"https://laohu8.com/S/PLC\">PLC</a> </b>(NASDAQ: AZN). It is approved in China and Japan for chronic kidney disease-induced anemia, and awaits clearance in the U.S. and Europe for the same indication.</p>\n<p>It is also being evaluated for anemia in myelodysplastic syndrome patients and chemotherapy-induced anemia.</p>\n<p>FibroGen's fibrotic portfolio consists of pamrevlumab, which is being evaluated for multiple indications such as pancreatic cancer, Duchenne muscular atrophy, idiopathic pulmonary fibrosis and COVID-19.</p>\n<p>The company's announcement March 1 regarding the FDA's decision to hold an Adcom meeting ahead of the roxadustat PDUFA date of March 20 led to a sell-off in shares. The stock has pulled back over 30% since the start of March.</p>\n<p>\"At this reduced share price we believe that the market is still undervaluing FibroGen's anti-CTGF antibody pamrevlumab, which is in phase 3 studies for three large indications, as well as roxadustat in China and Japan,\" SVB Leerink analyst Geoffrey Porges said in a note.</p>\n<p>Even in the bear-case scenario of no approval for roxadustat in the U.S. and EU, FibroGen shares are worth $52/share, according to the analyst.</p>\n<p>This, the analyst said, is an unlikely scenario. Approval for the drug in both dialysis-dependent and non-dialysis-dependent patients&nbsp;could push the stock value up to $85, he said.</p>\n<p>The company recently initiated a Phase 3 study of pamrevlumab in combination with systemic corticosteroids in patients with ambulatory Duchenne muscular dystrophy.</p>\n<p>FibroGen expects to end 2021 with cash in the range of $660 to $670 million.</p>\n<p><b>Upcoming Catalysts: </b>Phase 2 data for roxadustat in chemotherapy-induced anemia in the second-half of 2021.</p>\n<p>Data from the Phase 3 study of roxadustat in anemia of myelodysplastic syndromes in the first half of 2022.</p>\n<p>Resection data from the Phase 3 study of pamrevlumab in locally advanced pancreatic cancer in the second half of 2022.</p>\n<p>Data from the Phase 3 study of pamrevlumab in DMD in the second half of 2022.</p>\n<p><i>Related Link: Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates</i></p>\n<p><b>Replimune: </b> Replimune is a pursuing a novel approach in taking on cancer with its oncolytic immunotherapy. It uses viruses that have been modified to selectively replicate in tumor cells and kill them. In a two-pronged strategy, oncolytic viruses kill tumors at the site of injection and also activate immune system to kill cancer cells anywhere in the body.</p>\n<p>The company's lead candidate RP1 is being evaluated as a monotherapy as well as in combination with anti-PD1 antibodies such as Bristol-Myers Squibb's Opdivo and the&nbsp;<b><a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> </b>(NASDAQ: SNY)-<b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a>, Inc. </b>(NASDAQ: REGN) combo's Libtayo for multiple cancer types such as melanoma, non-melanoma skin cancer, micro instability-high cancers, non-small cell lung cancer, or NSCLC, and cutaneous squamous cell carcinoma, or CSCC.</p>\n<p>RP2 and RP2 are being studied as monotherapy option and in combination with anti-PD1 antibodies against solid tumors.</p>\n<p>\"While the oncolytic virus landscape is competitive, we believe REPL has a lower risk profile given similarities between REPL's approach and the clinically validated T-Vec approach and the fact that REPL is being led by the same team that developed T-Vec,\" SVB Leerink analyst Chang said.</p>\n<p>The cash balance of $493.3 million as of Dec. 31, the company said, will fund its operating expenses and capital expenditure requirements into the second half of 2024.</p>\n<p><b>Upcoming Catalysts: </b>Initial data for RP1 in new indications such as anti-PD1 failed NSCLC, anti-PD1 failed CSCC and CSCC solid organ transplant recipient patients due in 2021.</p>\n<p>Updates across all RP1 programs anticipated in 2021.</p>\n<p>Initial Phase 1 data for RP2 in combination with Opdivo due in 2021.</p>\n<p>Initial single-agent data for RP3 in 2021.</p>\n<p><b>Screening Criteria Used: </b>Market cap of over $300 million.</p>\n<p>Average trading volume of over 100,000.</p>\n<p>Cash runway of two-plus years.</p>\n<p>Sell-side rating of Buy or above.</p>\n<p>Key upcoming catalysts.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Biotech Stocks That Could Double In 12 Months</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Biotech Stocks That Could Double In 12 Months\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-03-18 14:28</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><img src=\"https://static.tigerbbs.com/99883de80af9932feab97ad0486ef6d3\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p>Biotech stocks are risky investment bets that can swing an investor's fortunes in a big way. An investment decision backed by careful scrutiny and analysis&nbsp;— of a company's&nbsp;pipeline, collaborations, fundamentals, key make-or-break events and cash runway&nbsp;— can fetch disproportionate returns.</p>\n<p>Here are three biopharma stocks that have the potential to more than double from current levels:</p>\n<ul>\n <li><b>Immatics </b>(NASDAQ: IMTX)</li>\n <li><b><a href=\"https://laohu8.com/S/FGEN\">FibroGen, Inc</a>. </b>(NASDAQ: FGEN)</li>\n <li><b>Replimune Group, Inc. </b>(NASDAQ: REPL)</li>\n <li><b>Immatics: </b> Immatics is a clinical-stage biopharma engaged in the discovery and development of T cell directing cancer immunotherapies.</li>\n</ul>\n<p>The shares of the German biotech were listed on the Nasdaq in July 2020 following its business combination with Arya Sciences Acquisition Corp, a SPAC sponsored by Perceptive Advisors.</p>\n<p><b>The Pipeline: </b> The company's T cell receptor (TCR)-based&nbsp;immunotherapies offer a targeted therapy to patients with high medical need. It has two lead product classes, namely engineered Adoptive Cell Therapies, or ACTengine, and antibody-like TCR Bispecifics, or TCER.</p>\n<p>ACTengine is based on genetically engineering patients own T cells —&nbsp;a type of blood cells that are key to the immune system —&nbsp;with a TCR to recognize the cancer target. This would program the T cells to attack the tumor. These engineered T cells are then multiplied in labs and reinfused into the patients to treat the tumor.</p>\n<p>The product candidates belonging to the class ACT are IMA201, IMA 202 and IMA203, which are in Phase 1 trials, as well as IMA204, which is in preclinical development. IMA301 is preclinical stage ACT allo product candidate.</p>\n<p>IMA401 and IMA402 are two preclinical TCR bispecifics candidates.</p>\n<p>The company has a string of partnerships with large biopharma companies such as <b>Amgen Inc. </b>(NASDAQ: AMGN), <b>Bristol-Myers Squibb Company </b>(NYSE: BMY) and <b>GlaxoSmithKline plc </b>(NYSE: GSK).</p>\n<p>\"Overall, we view TCR approaches as potentially transformational for the solid tumor therapeutic space, with the ability to target a wide range of antigens not accessible by CAR-T or classical antibody approaches,\" SVB Leerink analyst Jonathan Chang said in a note.</p>\n<p>Although competition is steadily increasing, Immatics' comprehensive TCR-based immunotherapy approach will expand the potential utilization of TCRs across a broad range of tumor types and stages, the analyst said.</p>\n<p>Cash and cash equivalents as well as other financial assets stood at $303.6 million&nbsp;as of Sept, 30, 2020, providing cash runway into 2023.</p>\n<p><b>Upcoming Catalysts: </b>Combined initial data readout from its ACTengine product candidates,&nbsp;IMA201 and IMA 202,&nbsp;in solid tumors and IMA203 in hematologic malignancies and solid cancers in the first quarter.</p>\n<p>Investigational new drug application filing for IMA204 in solid cancers in 2021.</p>\n<p>IND filing for IMA301 in hematological and solid cancers in 2022.</p>\n<p>IND filing for IMA-401 in solid cancers by year end 2022.</p>\n<p><b>FibroGen: </b> FibroGen focuses on advancing treatment options for anemia, fibrotic disease and cancer, leveraging its expertise in fibrosis and hypoxia-inducible factor biology.</p>\n<p>HIF is a protein complex that plays a key role in the body's response to low oxygen concentrations and inflammation.</p>\n<p><b>The Pipeline: </b> FibroGen's anemia drug roxadustat is being developed along with <b>AstraZeneca <a href=\"https://laohu8.com/S/PLC\">PLC</a> </b>(NASDAQ: AZN). It is approved in China and Japan for chronic kidney disease-induced anemia, and awaits clearance in the U.S. and Europe for the same indication.</p>\n<p>It is also being evaluated for anemia in myelodysplastic syndrome patients and chemotherapy-induced anemia.</p>\n<p>FibroGen's fibrotic portfolio consists of pamrevlumab, which is being evaluated for multiple indications such as pancreatic cancer, Duchenne muscular atrophy, idiopathic pulmonary fibrosis and COVID-19.</p>\n<p>The company's announcement March 1 regarding the FDA's decision to hold an Adcom meeting ahead of the roxadustat PDUFA date of March 20 led to a sell-off in shares. The stock has pulled back over 30% since the start of March.</p>\n<p>\"At this reduced share price we believe that the market is still undervaluing FibroGen's anti-CTGF antibody pamrevlumab, which is in phase 3 studies for three large indications, as well as roxadustat in China and Japan,\" SVB Leerink analyst Geoffrey Porges said in a note.</p>\n<p>Even in the bear-case scenario of no approval for roxadustat in the U.S. and EU, FibroGen shares are worth $52/share, according to the analyst.</p>\n<p>This, the analyst said, is an unlikely scenario. Approval for the drug in both dialysis-dependent and non-dialysis-dependent patients&nbsp;could push the stock value up to $85, he said.</p>\n<p>The company recently initiated a Phase 3 study of pamrevlumab in combination with systemic corticosteroids in patients with ambulatory Duchenne muscular dystrophy.</p>\n<p>FibroGen expects to end 2021 with cash in the range of $660 to $670 million.</p>\n<p><b>Upcoming Catalysts: </b>Phase 2 data for roxadustat in chemotherapy-induced anemia in the second-half of 2021.</p>\n<p>Data from the Phase 3 study of roxadustat in anemia of myelodysplastic syndromes in the first half of 2022.</p>\n<p>Resection data from the Phase 3 study of pamrevlumab in locally advanced pancreatic cancer in the second half of 2022.</p>\n<p>Data from the Phase 3 study of pamrevlumab in DMD in the second half of 2022.</p>\n<p><i>Related Link: Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates</i></p>\n<p><b>Replimune: </b> Replimune is a pursuing a novel approach in taking on cancer with its oncolytic immunotherapy. It uses viruses that have been modified to selectively replicate in tumor cells and kill them. In a two-pronged strategy, oncolytic viruses kill tumors at the site of injection and also activate immune system to kill cancer cells anywhere in the body.</p>\n<p>The company's lead candidate RP1 is being evaluated as a monotherapy as well as in combination with anti-PD1 antibodies such as Bristol-Myers Squibb's Opdivo and the&nbsp;<b><a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> </b>(NASDAQ: SNY)-<b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a>, Inc. </b>(NASDAQ: REGN) combo's Libtayo for multiple cancer types such as melanoma, non-melanoma skin cancer, micro instability-high cancers, non-small cell lung cancer, or NSCLC, and cutaneous squamous cell carcinoma, or CSCC.</p>\n<p>RP2 and RP2 are being studied as monotherapy option and in combination with anti-PD1 antibodies against solid tumors.</p>\n<p>\"While the oncolytic virus landscape is competitive, we believe REPL has a lower risk profile given similarities between REPL's approach and the clinically validated T-Vec approach and the fact that REPL is being led by the same team that developed T-Vec,\" SVB Leerink analyst Chang said.</p>\n<p>The cash balance of $493.3 million as of Dec. 31, the company said, will fund its operating expenses and capital expenditure requirements into the second half of 2024.</p>\n<p><b>Upcoming Catalysts: </b>Initial data for RP1 in new indications such as anti-PD1 failed NSCLC, anti-PD1 failed CSCC and CSCC solid organ transplant recipient patients due in 2021.</p>\n<p>Updates across all RP1 programs anticipated in 2021.</p>\n<p>Initial Phase 1 data for RP2 in combination with Opdivo due in 2021.</p>\n<p>Initial single-agent data for RP3 in 2021.</p>\n<p><b>Screening Criteria Used: </b>Market cap of over $300 million.</p>\n<p>Average trading volume of over 100,000.</p>\n<p>Cash runway of two-plus years.</p>\n<p>Sell-side rating of Buy or above.</p>\n<p>Key upcoming catalysts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f481c85fbd4ff2fb9b3089eae9b7a782","relate_stocks":{"REPL":"Replimune Group Inc.","FGEN":"FibroGen, Inc","IMTX":"Immatics N.V."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2120518003","content_text":"Biotech stocks are risky investment bets that can swing an investor's fortunes in a big way. An investment decision backed by careful scrutiny and analysis — of a company's pipeline, collaborations, fundamentals, key make-or-break events and cash runway — can fetch disproportionate returns.\nHere are three biopharma stocks that have the potential to more than double from current levels:\n\nImmatics (NASDAQ: IMTX)\nFibroGen, Inc. (NASDAQ: FGEN)\nReplimune Group, Inc. (NASDAQ: REPL)\nImmatics:  Immatics is a clinical-stage biopharma engaged in the discovery and development of T cell directing cancer immunotherapies.\n\nThe shares of the German biotech were listed on the Nasdaq in July 2020 following its business combination with Arya Sciences Acquisition Corp, a SPAC sponsored by Perceptive Advisors.\nThe Pipeline:  The company's T cell receptor (TCR)-based immunotherapies offer a targeted therapy to patients with high medical need. It has two lead product classes, namely engineered Adoptive Cell Therapies, or ACTengine, and antibody-like TCR Bispecifics, or TCER.\nACTengine is based on genetically engineering patients own T cells — a type of blood cells that are key to the immune system — with a TCR to recognize the cancer target. This would program the T cells to attack the tumor. These engineered T cells are then multiplied in labs and reinfused into the patients to treat the tumor.\nThe product candidates belonging to the class ACT are IMA201, IMA 202 and IMA203, which are in Phase 1 trials, as well as IMA204, which is in preclinical development. IMA301 is preclinical stage ACT allo product candidate.\nIMA401 and IMA402 are two preclinical TCR bispecifics candidates.\nThe company has a string of partnerships with large biopharma companies such as Amgen Inc. (NASDAQ: AMGN), Bristol-Myers Squibb Company (NYSE: BMY) and GlaxoSmithKline plc (NYSE: GSK).\n\"Overall, we view TCR approaches as potentially transformational for the solid tumor therapeutic space, with the ability to target a wide range of antigens not accessible by CAR-T or classical antibody approaches,\" SVB Leerink analyst Jonathan Chang said in a note.\nAlthough competition is steadily increasing, Immatics' comprehensive TCR-based immunotherapy approach will expand the potential utilization of TCRs across a broad range of tumor types and stages, the analyst said.\nCash and cash equivalents as well as other financial assets stood at $303.6 million as of Sept, 30, 2020, providing cash runway into 2023.\nUpcoming Catalysts: Combined initial data readout from its ACTengine product candidates, IMA201 and IMA 202, in solid tumors and IMA203 in hematologic malignancies and solid cancers in the first quarter.\nInvestigational new drug application filing for IMA204 in solid cancers in 2021.\nIND filing for IMA301 in hematological and solid cancers in 2022.\nIND filing for IMA-401 in solid cancers by year end 2022.\nFibroGen:  FibroGen focuses on advancing treatment options for anemia, fibrotic disease and cancer, leveraging its expertise in fibrosis and hypoxia-inducible factor biology.\nHIF is a protein complex that plays a key role in the body's response to low oxygen concentrations and inflammation.\nThe Pipeline:  FibroGen's anemia drug roxadustat is being developed along with AstraZeneca PLC (NASDAQ: AZN). It is approved in China and Japan for chronic kidney disease-induced anemia, and awaits clearance in the U.S. and Europe for the same indication.\nIt is also being evaluated for anemia in myelodysplastic syndrome patients and chemotherapy-induced anemia.\nFibroGen's fibrotic portfolio consists of pamrevlumab, which is being evaluated for multiple indications such as pancreatic cancer, Duchenne muscular atrophy, idiopathic pulmonary fibrosis and COVID-19.\nThe company's announcement March 1 regarding the FDA's decision to hold an Adcom meeting ahead of the roxadustat PDUFA date of March 20 led to a sell-off in shares. The stock has pulled back over 30% since the start of March.\n\"At this reduced share price we believe that the market is still undervaluing FibroGen's anti-CTGF antibody pamrevlumab, which is in phase 3 studies for three large indications, as well as roxadustat in China and Japan,\" SVB Leerink analyst Geoffrey Porges said in a note.\nEven in the bear-case scenario of no approval for roxadustat in the U.S. and EU, FibroGen shares are worth $52/share, according to the analyst.\nThis, the analyst said, is an unlikely scenario. Approval for the drug in both dialysis-dependent and non-dialysis-dependent patients could push the stock value up to $85, he said.\nThe company recently initiated a Phase 3 study of pamrevlumab in combination with systemic corticosteroids in patients with ambulatory Duchenne muscular dystrophy.\nFibroGen expects to end 2021 with cash in the range of $660 to $670 million.\nUpcoming Catalysts: Phase 2 data for roxadustat in chemotherapy-induced anemia in the second-half of 2021.\nData from the Phase 3 study of roxadustat in anemia of myelodysplastic syndromes in the first half of 2022.\nResection data from the Phase 3 study of pamrevlumab in locally advanced pancreatic cancer in the second half of 2022.\nData from the Phase 3 study of pamrevlumab in DMD in the second half of 2022.\nRelated Link: Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates\nReplimune:  Replimune is a pursuing a novel approach in taking on cancer with its oncolytic immunotherapy. It uses viruses that have been modified to selectively replicate in tumor cells and kill them. In a two-pronged strategy, oncolytic viruses kill tumors at the site of injection and also activate immune system to kill cancer cells anywhere in the body.\nThe company's lead candidate RP1 is being evaluated as a monotherapy as well as in combination with anti-PD1 antibodies such as Bristol-Myers Squibb's Opdivo and the Sanofi (NASDAQ: SNY)-Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) combo's Libtayo for multiple cancer types such as melanoma, non-melanoma skin cancer, micro instability-high cancers, non-small cell lung cancer, or NSCLC, and cutaneous squamous cell carcinoma, or CSCC.\nRP2 and RP2 are being studied as monotherapy option and in combination with anti-PD1 antibodies against solid tumors.\n\"While the oncolytic virus landscape is competitive, we believe REPL has a lower risk profile given similarities between REPL's approach and the clinically validated T-Vec approach and the fact that REPL is being led by the same team that developed T-Vec,\" SVB Leerink analyst Chang said.\nThe cash balance of $493.3 million as of Dec. 31, the company said, will fund its operating expenses and capital expenditure requirements into the second half of 2024.\nUpcoming Catalysts: Initial data for RP1 in new indications such as anti-PD1 failed NSCLC, anti-PD1 failed CSCC and CSCC solid organ transplant recipient patients due in 2021.\nUpdates across all RP1 programs anticipated in 2021.\nInitial Phase 1 data for RP2 in combination with Opdivo due in 2021.\nInitial single-agent data for RP3 in 2021.\nScreening Criteria Used: Market cap of over $300 million.\nAverage trading volume of over 100,000.\nCash runway of two-plus years.\nSell-side rating of Buy or above.\nKey upcoming catalysts.","news_type":1},"isVote":1,"tweetType":1,"viewCount":207,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160316118,"gmtCreate":1623772172034,"gmtModify":1703819026950,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160316118","repostId":"1150591447","repostType":4,"repost":{"id":"1150591447","pubTimestamp":1623769391,"share":"https://www.laohu8.com/m/news/1150591447?lang=&edition=full","pubTime":"2021-06-15 23:03","market":"us","language":"en","title":"Here's a complete trader playbook for every outcome from the key Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1150591447","media":"CNBC","summary":"The Federal Reserve’s all-important policy meeting this week is going to affect where investors put ","content":"<div>\n<p>The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's a complete trader playbook for every outcome from the key Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's a complete trader playbook for every outcome from the key Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF"},"source_url":"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1150591447","content_text":"The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day meeting Wednesday, could start preliminary discussions about scaling back the unprecedented bond-buying programs that aided the economy during the pandemic. Some market participants believe it’s still too soon for the central bank to signal such a tapering action, while others think the Fed will be able to find a happy medium that won’t upset the markets.\nEach scenario has different investing implications as they are expected to make big moves across asset classes.\nHere’s a playbook for traders on every scenario from the central bank’s key meeting.\nIf the Fed signals it’s staying with easy policies\nThe Fed could reiterate its transitory stance on inflation, ignoring the pick-up in price pressures reflected in recent economic data. If the central bank says its not time to remove accommodative policies and it’s not concerned about inflation, investors should stick with hedges against rising prices like commodities and stocks with high pricing power, investment banks found.\nBank of America screened S&P 500 companies that its analysts believe have the most pricing power and ability to expand margins at times of rising prices. The stocks include a few chipmakers —Nvidia,Texas InstrumentsandBroadcom— as well as consumer plays likeHome Depot,NikeandPepsiCo.Energy dividend payerExxon Mobilis also on the list.\nUBS also developed a framework for scoring corporate pricing agility, which considers pricing power, margin momentum and input cost exposure. For pricing power, UBS quantified the extent to which a company can raise prices over and above costs. For margin momentum, UBS tracked corporate pricing trends using its proprietary pricing mapping.\nFor input cost exposure, UBS searched for companies with negative sentiment around commodity and transport costs on earnings calls.\n\nBillionaire hedge fund manager Paul Tudor Jones said earlier this week that investors should “go all in on the inflation trades” if the Fed keeps ignoring higher prices.\n“If they treat these numbers — which were material events, they were very material —if they treat them with nonchalance, I think it’s just a green light to bet heavily on every inflation trade,” Tudor Jones said on “Squawk Box”on Monday.\n“If they say, ‘We’re on path, things are good,’ then I would just go all in on the inflation trades. I’d probably buy commodities, buy crypto, buy gold,” added Tudor Jones, who called the stock market crash in 1987.\nThe legendary investor believe cryptocurrencies and other commodities are favorable inflation hedges. Other than buying the commodities outright, investors could also bet on related exchange-traded funds, like gold miner ETFs.\nThe VanEck Vectors Gold Miners ETF (GDX),the biggest gold miner ETF with more than $14 billion in assets under management, has outperformed the populargold ETF GLDso far this year.\nIf the Fed signals it’s time to start removing easy policies\nAnother widely speculated scenario is for the Fed to signal that it’s nearing the time to dial back easy policy saying it will start tapering soon and move up its forecast for a rate increase. Under such a case where the central bank isn’t sufficiently dovish, many expect bond yields to shoot higher.\n“It could easily move longer yields higher,” said Kristina Hooper, Invesco’s chief global market strategist. “A revised dot plot could be one way to do that if it shows the anticipation of earlier or more aggressive rate hikes. And Fed Chair Jay Powell could easily push rates up if he shares that the Fed has started discussing tapering or suggests tapering could start in the next several months.”\nTudor Jones warned that this scenario could lead to another taper tantrum that could cause a correction in stocks.\n“If they course correct, if they say, ‘We’ve got incoming data, we’ve accomplished our mission or we’re on the way very rapidly to accomplishing our mission on employment,’ then you’re going to get a taper tantrum,”Tudor Jones said on Monday. “You’re going to get a sell-off in fixed income. You’re going to get a correction in stocks.”\nCNBC Pro combed through the returns of all S&P 500 stocks during the last five significant spikes in the 10-year Treasury yield. These five periods of a sharp move in rates occurred between 2003 and 2006, 2008 and 2009, 2012 and 2013, 2016 and 2018, and 2020 through now.\nAfter we found the stocks that beat the market every time, we looked for the names that are well-loved by analysts on Wall Street today. The stocks’ average gains during those rising interest rate periods are listed below, along with the percentage of analysts with buy ratings right now.\n\nBank of America’s head of U.S. equity and quantitative strategy Savita Subramanian is advising clients to buy high-quality stocks when tapering nears. High-quality stocks have a “B+” or better S&P quality rating.\nSubramanian said during the 2013 taper tantrum, high-quality names outperformed their low-quality counterparts by 1.3 percentage points from peak to trough in May and June.\nA hint at removing stimulus could also hurt stocks that are most sensitive to the economic recovery, including cyclicals like financials, energy and materials.\n“More hawkish = lower growth. Cyclicals should underperform,” Dennis DeBusschere, macro research analyst at Evercore ISI, said in a note. “The fact that hawkish concerns are being brought up at the same time people believe the reflation trade is in trouble and you have a poor Cyclical backdrop.”\nSo far in 2021, the energy sector has been the biggest winner among the 11 S&P 500 groupings, up 46%. Financials and real estate both gained more than 20% this year.\nIf the Fed makes both camps happy\nA third scenario could occur in which the Fed signals that it is concerned about inflation, but the central bank is not yet ready to taper.\nIf Fed chair Jerome Powell admits the discussion of tapering but nothing has been decided, then the market will likely see a modest rally, led by tech stocks, according to Tom Essaye, founder of the Sevens Report.\n“This is essentially the outcome that Powell and the Fed have been telegraphing for the past several weeks,” Essaye said. “This would be a continuation of the past two weeks’ Goldilocks market outlook. This outcome would help the S&P 500 extend last week’s breakout.”\nInvestors have been rotating back to tech as of late with bond yields coming down. The tech-heavyNasdaq Compositehas rallied about 2.5% this month, hitting a record close on Monday, its first all-time high since April 26. In comparison, the S&P 500 has risen just under 1% in June.\n“This is what the Fed has been doing for the last several months — warning that an inflation surge was coming but that it is transitory so no need to taper,” Jim Paulsen, chief investment strategist at the Leuthold Group, told CNBC. “Moreover, this is probably the most expected outcome from the Fed meeting.”\n“Yes, there may be comments by members that the time to start talking about tapering is here, but I think Powell will continue to suggest that inflation is up as expected but is not yet acting any differently than anticipated,” added Paulsen.\nThis year’s pullback in tech stocks has opened some opportunities in high-quality names that are now trading at a discount, according to top-rated technology analyst Toni Sacconaghi of Bernstein.\nThe Wall Street firm found several technology stocks that have inexpensive valuations and are high in quality. Bernstein screened for the cheapest tech names based on their forward price-to-earnings ratio. The firm also assigned each stock with a quality score.","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160318702,"gmtCreate":1623772160106,"gmtModify":1703819026465,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/160318702","repostId":"1187337744","repostType":4,"repost":{"id":"1187337744","pubTimestamp":1623770439,"share":"https://www.laohu8.com/m/news/1187337744?lang=&edition=full","pubTime":"2021-06-15 23:20","market":"us","language":"en","title":"FOMC Preview: \"It's Like The Titanic Running At Full Speed. In Fog. At Night\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1187337744","media":"zerohedge","summary":"Perhaps it's prudent to ease up on the throttle.","content":"<p>There's an FOMC meeting this week and we are expecting a policy statement at 2:00 PM on Wednesday. Many commentators are calling this FOMC meeting the \"most important\" in recent years.</p>\n<p><u><i><b>Big picture … did the Fed move the goal posts?</b></i></u></p>\n<p>Let's look at some numbers.</p>\n<p>Monthly inflation: wage growth +.5%, PCE +.7%, PPI +.6%, CPI +.7% -<b>these are real scary when they're annualized</b>.</p>\n<p>GDP is projected to be 6.4% and the unemployment rate is projected to be 5.5% at the next report.</p>\n<p>With these numbers, U.S. monetary is still \"<b>all in.\"</b></p>\n<p>Overnight rates are at 0% and QE running at $120 billion a month.</p>\n<p><b>On top of that, there will be more stimulus as the economy continues to reopen.</b></p>\n<p>In my book, this economic situation calls for attention.</p>\n<p><u><i><b>It's like the Titanic running at full speed. In fog. At night.</b></i></u></p>\n<p>Perhaps it's prudent to ease up on the throttle.</p>\n<p></p>\n<p></p>","source":"lsy1583725640930","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FOMC Preview: \"It's Like The Titanic Running At Full Speed. In Fog. At Night\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFOMC Preview: \"It's Like The Titanic Running At Full Speed. In Fog. At Night\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/fomc-preview-its-titanic-running-full-speed-fog-night><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There's an FOMC meeting this week and we are expecting a policy statement at 2:00 PM on Wednesday. Many commentators are calling this FOMC meeting the \"most important\" in recent years.\nBig picture … ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/fomc-preview-its-titanic-running-full-speed-fog-night\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.zerohedge.com/markets/fomc-preview-its-titanic-running-full-speed-fog-night","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187337744","content_text":"There's an FOMC meeting this week and we are expecting a policy statement at 2:00 PM on Wednesday. Many commentators are calling this FOMC meeting the \"most important\" in recent years.\nBig picture … did the Fed move the goal posts?\nLet's look at some numbers.\nMonthly inflation: wage growth +.5%, PCE +.7%, PPI +.6%, CPI +.7% -these are real scary when they're annualized.\nGDP is projected to be 6.4% and the unemployment rate is projected to be 5.5% at the next report.\nWith these numbers, U.S. monetary is still \"all in.\"\nOvernight rates are at 0% and QE running at $120 billion a month.\nOn top of that, there will be more stimulus as the economy continues to reopen.\nIn my book, this economic situation calls for attention.\nIt's like the Titanic running at full speed. In fog. At night.\nPerhaps it's prudent to ease up on the throttle.","news_type":1},"isVote":1,"tweetType":1,"viewCount":45,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":351800139,"gmtCreate":1616579995521,"gmtModify":1704795922758,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hmmm","listText":"Hmmm","text":"Hmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/351800139","repostId":"1178385748","repostType":4,"repost":{"id":"1178385748","pubTimestamp":1616579432,"share":"https://www.laohu8.com/m/news/1178385748?lang=&edition=full","pubTime":"2021-03-24 17:50","market":"us","language":"en","title":"The End of Tesla’s Dominance May Be Closer Than It Appears","url":"https://stock-news.laohu8.com/highlight/detail?id=1178385748","media":"Bloomberg","summary":"Elon Musk’s upstart still rules, but traditional automakers are catching up fast.\nHe doesn’t date a ","content":"<p>Elon Musk’s upstart still rules, but traditional automakers are catching up fast.</p>\n<p>He doesn’t date a synth-pop star, publicly puff on blunts, or profess to want to die on Mars, but Herbert Diess is starting to look and sound an awful lot like&nbsp;Elon Musk.</p>\n<p>The chief executive officer of&nbsp;Volkswagen AG&nbsp;kicked off a March 15 news conference modeled after&nbsp;Tesla Inc.’s “Battery Day”—Diess called his “Power Day”—by declaring that there’s only one way to quickly reduce emissions from transportation: Go electric. Skeptics could be forgiven for raising their eyebrows at that message, coming as it was from the same carmaker that spent years gaslighting the world about “clean diesel.” But VW is finally seeing the payoff from its&nbsp;five-year effort&nbsp;to create a standardized platform to underpin dozens of electric models. “Many in the industry questioned our approach,” Diess said during the two-hour infomercial he led from VW’s headquarters in the German city of Wolfsburg. “Today they are following suit, while we are reaping the fruit.”</p>\n<p>VW last year became the&nbsp;No. 1 electric-vehicle maker in Europe, where sales of battery-powered cars surged thanks to stricter carbon dioxide limits. After the introduction of the&nbsp;ID.3&nbsp;hatchback in 2020, the ID.4 crossover—the first global model based on VW’s electric platform—is starting to reach showrooms from Shanghai to Chicago. This year, VW plans to deliver 1 million plug-in hybrid and fully electric vehicles, and Diess aims to surpass Tesla in EV sales no later than 2025. Some analysts predict it will happen much sooner.</p>\n<p><img src=\"https://static.tigerbbs.com/f575bfbac7cb6073a2daaddcc86628dc\" tg-width=\"1251\" tg-height=\"610\"></p>\n<p>In addition to staging splashy events, mixing it up on Twitter, and spewing shameless bombast, Diess has something else in common with Musk lately: a&nbsp;stock price headed into the stratosphere. Sure, Tesla’s sky-high valuation means Musk could afford to buy VW tomorrow if he so desired (he doesn’t), but VW’s common shares have jumped more than 80% this year. Musk has long said that he welcomes EV competition and that Tesla’s mission was to accelerate the advent of sustainable energy. He got what he wanted.</p>\n<p>EVs are shifting from what seemed like a one-man show to an extravaganza with an increasingly crowded stage. Although VW has as good a chance as anyone to share top billing with Tesla, what’s less clear is the rest of the cast.General Motors Co.&nbsp;CEO Mary Barra sent her stock price soaring in January when she said she wanted to&nbsp;phase out gas and diesel cars by 2035. Many Chinese manufacturers are rolling out budget EVs, and&nbsp;Hyundai Motor Co.&nbsp;is planning almost two dozen models.Renault SA&nbsp;had a&nbsp;surprise hit&nbsp;in Europe last year with its Zoe, a battery-powered hatchback. In the U.S., Ford Motor’s Mustang Mach-E is hitting showrooms, and Amazon.com-backed Rivian Automotive and Lucid Motors—a Tesla clone that’s on track to raise $4.4 billion in funding—are seeking to replicate Musk’s success.</p>\n<p>Tesla has done to the auto industry what Netflix Inc. did to cable TV, speeding the shift away from internal combustion in much the same way easy access to<i>Breaking Bad</i>and hundreds of other shows spurred consumers to take the scissors to their Comcast contracts. But just as Netflix now sees a growing challenge from parts of the old guard—think Walt Disney Co. and HBO—incumbent automakers are starting to emulate the upstart. (Of course, cable TV companies also face a threat from the likes of Amazon.com Inc., Apple Inc., and Google, which in this analogy are … Amazon, Apple, and Google.)</p>\n<p>Even though Disney+ was years behind Netflix, Disney’s service has been a runaway success with new fare such as<i>The Mandalorian</i>offered alongside its deep catalog of classics like&nbsp;<i>Pinocchio</i>,<i>Toy Story</i>, and&nbsp;<i>Mulan</i>. Similarly, Diess has won over investors by making the case that VW can exploit something Tesla doesn’t have much of yet: scale. With a dozen brands that fill every nook and cranny of the auto market—and sales last year of 9.3 million vehicles, compared with a half-million for Tesla—VW is uniquely positioned to pool resources and bear the cost of developing new technologies. By next year, VW will have 27 models based on its standardized platform. “Our transformation will be fast,” Diess said at his event, “bigger than anything the industry has seen in the past century.”</p>\n<p>Like Musk, Diess is going big on batteries and charging stations. By 2025, VW and its partners will have more than 35,000&nbsp;public chargers around the world. And one element of its legal agreement with the U.S. and California over cheating on emissions tests was a pledge to spend $2 billion promoting plug-ins and building charging infrastructure. VW in 2017 set up an affiliate called Electrify America that now boasts the largest fast-charging network in the U.S. Diess is also planning a&nbsp;half-dozen battery factories&nbsp;in Europe, which Bloomberg&nbsp;NEF estimates will require an investment of almost $18 billion. The energy researcher says improvements in cell design, battery chemistry, and manufacturing put VW on track to cut the cost of batteries in half by as early as 2025. That could make its EVs cheaper than similarly equipped combustion cars.</p>\n<p>Some rivals insist VW’s&nbsp;headlong charge&nbsp;into electric cars is imprudent because they remain a sliver of global sales—roughly 3% of vehicles delivered worldwide last year.Toyota Motor Corp., which narrowly surpassed VW as the world’s largest automaker in 2020, has long argued hybrids are a more sensible intermediate solution. And&nbsp;BMW AG&nbsp;has embraced flexibility, building many of its models in various versions: gasoline-powered, hybrid, plug-in hybrid, and electric. “We think a one-propulsion strategy could be very dangerous,” CEO Oliver Zipse told&nbsp;Bloomberg Television&nbsp;on March 17. “The likelihood that 150, 160 markets in a very short period of time—and one decade is a very short period of time—will converge fully into one drivetrain is highly unlikely.”</p>\n<p>Diess has no plans to hit the brakes. Even as the first models from the current platform start to roll out, VW is furiously developing a separate set of standard components for electric vehicles from Audi, Porsche, and its other upscale brands. That premium platform promises speedier charging times, greater range, and faster acceleration than the first-generation models. By the middle of the decade, VW says it will have a single scalable system to underpin all its battery-powered cars—no matter the brand or segment—as it aims to sell 26 million of them in the next 10 years. “They’ve got confidence that they can catch up with Tesla,” says Michael Dean, an analyst at Bloomberg Intelligence, who expects VW to take the global EV crown by 2023. “Their foray into electrification is serious.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The End of Tesla’s Dominance May Be Closer Than It Appears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe End of Tesla’s Dominance May Be Closer Than It Appears\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-24 17:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://bloomberg.com/news/articles/2021-03-24/tesla-tsla-and-elon-musk-s-dominance-is-threatened-by-volkswagen><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elon Musk’s upstart still rules, but traditional automakers are catching up fast.\nHe doesn’t date a synth-pop star, publicly puff on blunts, or profess to want to die on Mars, but Herbert Diess is ...</p>\n\n<a href=\"http://bloomberg.com/news/articles/2021-03-24/tesla-tsla-and-elon-musk-s-dominance-is-threatened-by-volkswagen\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"http://bloomberg.com/news/articles/2021-03-24/tesla-tsla-and-elon-musk-s-dominance-is-threatened-by-volkswagen","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178385748","content_text":"Elon Musk’s upstart still rules, but traditional automakers are catching up fast.\nHe doesn’t date a synth-pop star, publicly puff on blunts, or profess to want to die on Mars, but Herbert Diess is starting to look and sound an awful lot like Elon Musk.\nThe chief executive officer of Volkswagen AG kicked off a March 15 news conference modeled after Tesla Inc.’s “Battery Day”—Diess called his “Power Day”—by declaring that there’s only one way to quickly reduce emissions from transportation: Go electric. Skeptics could be forgiven for raising their eyebrows at that message, coming as it was from the same carmaker that spent years gaslighting the world about “clean diesel.” But VW is finally seeing the payoff from its five-year effort to create a standardized platform to underpin dozens of electric models. “Many in the industry questioned our approach,” Diess said during the two-hour infomercial he led from VW’s headquarters in the German city of Wolfsburg. “Today they are following suit, while we are reaping the fruit.”\nVW last year became the No. 1 electric-vehicle maker in Europe, where sales of battery-powered cars surged thanks to stricter carbon dioxide limits. After the introduction of the ID.3 hatchback in 2020, the ID.4 crossover—the first global model based on VW’s electric platform—is starting to reach showrooms from Shanghai to Chicago. This year, VW plans to deliver 1 million plug-in hybrid and fully electric vehicles, and Diess aims to surpass Tesla in EV sales no later than 2025. Some analysts predict it will happen much sooner.\n\nIn addition to staging splashy events, mixing it up on Twitter, and spewing shameless bombast, Diess has something else in common with Musk lately: a stock price headed into the stratosphere. Sure, Tesla’s sky-high valuation means Musk could afford to buy VW tomorrow if he so desired (he doesn’t), but VW’s common shares have jumped more than 80% this year. Musk has long said that he welcomes EV competition and that Tesla’s mission was to accelerate the advent of sustainable energy. He got what he wanted.\nEVs are shifting from what seemed like a one-man show to an extravaganza with an increasingly crowded stage. Although VW has as good a chance as anyone to share top billing with Tesla, what’s less clear is the rest of the cast.General Motors Co. CEO Mary Barra sent her stock price soaring in January when she said she wanted to phase out gas and diesel cars by 2035. Many Chinese manufacturers are rolling out budget EVs, and Hyundai Motor Co. is planning almost two dozen models.Renault SA had a surprise hit in Europe last year with its Zoe, a battery-powered hatchback. In the U.S., Ford Motor’s Mustang Mach-E is hitting showrooms, and Amazon.com-backed Rivian Automotive and Lucid Motors—a Tesla clone that’s on track to raise $4.4 billion in funding—are seeking to replicate Musk’s success.\nTesla has done to the auto industry what Netflix Inc. did to cable TV, speeding the shift away from internal combustion in much the same way easy access toBreaking Badand hundreds of other shows spurred consumers to take the scissors to their Comcast contracts. But just as Netflix now sees a growing challenge from parts of the old guard—think Walt Disney Co. and HBO—incumbent automakers are starting to emulate the upstart. (Of course, cable TV companies also face a threat from the likes of Amazon.com Inc., Apple Inc., and Google, which in this analogy are … Amazon, Apple, and Google.)\nEven though Disney+ was years behind Netflix, Disney’s service has been a runaway success with new fare such asThe Mandalorianoffered alongside its deep catalog of classics like Pinocchio,Toy Story, and Mulan. Similarly, Diess has won over investors by making the case that VW can exploit something Tesla doesn’t have much of yet: scale. With a dozen brands that fill every nook and cranny of the auto market—and sales last year of 9.3 million vehicles, compared with a half-million for Tesla—VW is uniquely positioned to pool resources and bear the cost of developing new technologies. By next year, VW will have 27 models based on its standardized platform. “Our transformation will be fast,” Diess said at his event, “bigger than anything the industry has seen in the past century.”\nLike Musk, Diess is going big on batteries and charging stations. By 2025, VW and its partners will have more than 35,000 public chargers around the world. And one element of its legal agreement with the U.S. and California over cheating on emissions tests was a pledge to spend $2 billion promoting plug-ins and building charging infrastructure. VW in 2017 set up an affiliate called Electrify America that now boasts the largest fast-charging network in the U.S. Diess is also planning a half-dozen battery factories in Europe, which Bloomberg NEF estimates will require an investment of almost $18 billion. The energy researcher says improvements in cell design, battery chemistry, and manufacturing put VW on track to cut the cost of batteries in half by as early as 2025. That could make its EVs cheaper than similarly equipped combustion cars.\nSome rivals insist VW’s headlong charge into electric cars is imprudent because they remain a sliver of global sales—roughly 3% of vehicles delivered worldwide last year.Toyota Motor Corp., which narrowly surpassed VW as the world’s largest automaker in 2020, has long argued hybrids are a more sensible intermediate solution. And BMW AG has embraced flexibility, building many of its models in various versions: gasoline-powered, hybrid, plug-in hybrid, and electric. “We think a one-propulsion strategy could be very dangerous,” CEO Oliver Zipse told Bloomberg Television on March 17. “The likelihood that 150, 160 markets in a very short period of time—and one decade is a very short period of time—will converge fully into one drivetrain is highly unlikely.”\nDiess has no plans to hit the brakes. Even as the first models from the current platform start to roll out, VW is furiously developing a separate set of standard components for electric vehicles from Audi, Porsche, and its other upscale brands. That premium platform promises speedier charging times, greater range, and faster acceleration than the first-generation models. By the middle of the decade, VW says it will have a single scalable system to underpin all its battery-powered cars—no matter the brand or segment—as it aims to sell 26 million of them in the next 10 years. “They’ve got confidence that they can catch up with Tesla,” says Michael Dean, an analyst at Bloomberg Intelligence, who expects VW to take the global EV crown by 2023. “Their foray into electrification is serious.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":327928699,"gmtCreate":1616052699111,"gmtModify":1704790244087,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327928699","repostId":"2120130261","repostType":4,"repost":{"id":"2120130261","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1616048501,"share":"https://www.laohu8.com/m/news/2120130261?lang=&edition=full","pubTime":"2021-03-18 14:21","market":"hk","language":"en","title":"U.N. body raises global economic growth forecast for 2021 to 4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2120130261","media":"Reuters","summary":"GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronge","content":"<p>GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronger-than-expected recovery in the United States, a report by the U.N. Conference on Trade and Development (UNCTAD) said on Thursday, revising up its previous forecast of 4.3%.</p>\n<p>The upwards revision from its previous forecast made last September factors in an expected boost in U.S. consumer spending on the back of progress distributing COVID-19 vaccines and a vast stimulus package, the report said.</p>\n<p>\"The global recovery that began in the third quarter of 2020 is expected to continue through 2021, albeit with a good deal of unevenness and unpredictability, reflecting epidemiological, policy and coordination uncertainties,\" the report said.</p>\n<p>Earlier this month, the OECD also revised higher its growth forecast for this year to 5.6 % from 4.2 %.</p>\n<p>However, the 22-page UNCTAD report called 'Out of the frying pan...into the fire?' said COVID-19 will have lasting economic consequences that will require continued government support. It said the main risk to the global outlook is a \"misguided return to austerity\".</p>\n<p>The report estimates that last year there was a 3.9 % drop in output as the spread of the coronavirus sparked lockdowns across the world.</p>\n<p>It called the impact \"exorbitant\", describing the \"destruction of income on an unprecedented scale\" with people in developing countries particularly hard hit.</p>\n<p>Still, it says it would have been worse had central banks not taken preemptive action to avoid financial meltdown. Relief packages and a bounce-back in commodity prices as well as the fast-tracking of vaccine development also helped, the report said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.N. body raises global economic growth forecast for 2021 to 4.7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.N. body raises global economic growth forecast for 2021 to 4.7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-18 14:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronger-than-expected recovery in the United States, a report by the U.N. Conference on Trade and Development (UNCTAD) said on Thursday, revising up its previous forecast of 4.3%.</p>\n<p>The upwards revision from its previous forecast made last September factors in an expected boost in U.S. consumer spending on the back of progress distributing COVID-19 vaccines and a vast stimulus package, the report said.</p>\n<p>\"The global recovery that began in the third quarter of 2020 is expected to continue through 2021, albeit with a good deal of unevenness and unpredictability, reflecting epidemiological, policy and coordination uncertainties,\" the report said.</p>\n<p>Earlier this month, the OECD also revised higher its growth forecast for this year to 5.6 % from 4.2 %.</p>\n<p>However, the 22-page UNCTAD report called 'Out of the frying pan...into the fire?' said COVID-19 will have lasting economic consequences that will require continued government support. It said the main risk to the global outlook is a \"misguided return to austerity\".</p>\n<p>The report estimates that last year there was a 3.9 % drop in output as the spread of the coronavirus sparked lockdowns across the world.</p>\n<p>It called the impact \"exorbitant\", describing the \"destruction of income on an unprecedented scale\" with people in developing countries particularly hard hit.</p>\n<p>Still, it says it would have been worse had central banks not taken preemptive action to avoid financial meltdown. Relief packages and a bounce-back in commodity prices as well as the fast-tracking of vaccine development also helped, the report said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2120130261","content_text":"GENEVA, March 18 (Reuters) - The global economy is set to grow by 4.7% this year thanks to a stronger-than-expected recovery in the United States, a report by the U.N. Conference on Trade and Development (UNCTAD) said on Thursday, revising up its previous forecast of 4.3%.\nThe upwards revision from its previous forecast made last September factors in an expected boost in U.S. consumer spending on the back of progress distributing COVID-19 vaccines and a vast stimulus package, the report said.\n\"The global recovery that began in the third quarter of 2020 is expected to continue through 2021, albeit with a good deal of unevenness and unpredictability, reflecting epidemiological, policy and coordination uncertainties,\" the report said.\nEarlier this month, the OECD also revised higher its growth forecast for this year to 5.6 % from 4.2 %.\nHowever, the 22-page UNCTAD report called 'Out of the frying pan...into the fire?' said COVID-19 will have lasting economic consequences that will require continued government support. It said the main risk to the global outlook is a \"misguided return to austerity\".\nThe report estimates that last year there was a 3.9 % drop in output as the spread of the coronavirus sparked lockdowns across the world.\nIt called the impact \"exorbitant\", describing the \"destruction of income on an unprecedented scale\" with people in developing countries particularly hard hit.\nStill, it says it would have been worse had central banks not taken preemptive action to avoid financial meltdown. Relief packages and a bounce-back in commodity prices as well as the fast-tracking of vaccine development also helped, the report said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":324320857,"gmtCreate":1615966709279,"gmtModify":1704789021336,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/324320857","repostId":"1180242005","repostType":4,"repost":{"id":"1180242005","pubTimestamp":1615966420,"share":"https://www.laohu8.com/m/news/1180242005?lang=&edition=full","pubTime":"2021-03-17 15:33","market":"us","language":"en","title":"The S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says","url":"https://stock-news.laohu8.com/highlight/detail?id=1180242005","media":"Business Insider","summary":"The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.","content":"<ul>\n <li><b>The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.</b></li>\n <li><b>The bank pointed to strong seasonality and a developing cup and handle pattern that generates a 4,270 price target on the S&amp;P 500.</b></li>\n <li><b>\"Seasonality shines in April, which is the strongest month of the November to April period and is up 66% of the time,\" BofA said.</b></li>\n</ul>\n<p>Record highs in the stock market will continue to be made over the next few weeks if a Tuesday note from Bank of America pans out.</p>\n<p>The bank expects the S&amp;P 500 to hit a 4,270 price target derived from&nbsp;a bullish cup and handle pattern, which represents potential upside of 8% from Monday's close.</p>\n<p>And it's a bullish backdrop for stocks to continue their uptrend based on seasonality data, as April is the strongest month of the best 6-month period of the year, according to the note.</p>\n<p>\"Seasonality shines in April, which is the strongest month of the November-April period and is up 66% of the time with an average return of 1.37%,\" BofA said. The bank's seasonality analysis is based on data going back to 1928.</p>\n<p>On top of that, April is the second best month behind July in terms of average return, and the second best month behind December in terms of the percentage of time up, according to BofA.</p>\n<p>From a technical perspective, BofA highlights big picture levels on the S&amp;P 500, based on a bullish cup and handle pattern formed last year. A cup and handle often resembles a cup, formed by a basing pattern that typically looks like a \"U,\" followed by a handle that is formed by a short-term down trend. This pattern usually extends an uptrend that is already in place.</p>\n<p>BofA's 4,270 price target on the S&amp;P 500 is based on a measured move of the depth of the cup formed in March of 2020 and the eventual breakout later in July.</p>\n<p>Also favoring continued upside for the S&amp;P 500 is new highs in Advance/Decline line, which indicates that underlying market breadth is strong. The Advance/Decline line measures the difference of stocks that are moving higher or lower on a daily basis.</p>\n<p>\"A bullish A-D line sets up the S&amp;P 500 for a breakout above 3,950 - 3,960 that would favor upside to 4,065 next with the 2020 cup and handle target at 4,270,\" BofA said.</p>\n<p>And if the S&amp;P 500 does falter, investors should look to big picture support levels at 3,700, 3,550, and 3,200, BofA highlighted.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b5e8c7f39d815d6d80277066e3cc5145\" tg-width=\"790\" tg-height=\"442\"><span>Bank of America</span></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 could surge 8% on strong seasonality and a bullish technical pattern, BofA says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-17 15:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/stock-market-outlook-sp500-to-strong-seasonality-bullish-technicals-bofa-2021-3-1030216115><strong>Business Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.\nThe bank pointed to strong seasonality and a developing cup and handle pattern that generates a 4,...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/stock-market-outlook-sp500-to-strong-seasonality-bullish-technicals-bofa-2021-3-1030216115\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://markets.businessinsider.com/news/stocks/stock-market-outlook-sp500-to-strong-seasonality-bullish-technicals-bofa-2021-3-1030216115","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180242005","content_text":"The stock market could continue its uptrend and surge 8%, Bank of America said in a note on Tuesday.\nThe bank pointed to strong seasonality and a developing cup and handle pattern that generates a 4,270 price target on the S&P 500.\n\"Seasonality shines in April, which is the strongest month of the November to April period and is up 66% of the time,\" BofA said.\n\nRecord highs in the stock market will continue to be made over the next few weeks if a Tuesday note from Bank of America pans out.\nThe bank expects the S&P 500 to hit a 4,270 price target derived from a bullish cup and handle pattern, which represents potential upside of 8% from Monday's close.\nAnd it's a bullish backdrop for stocks to continue their uptrend based on seasonality data, as April is the strongest month of the best 6-month period of the year, according to the note.\n\"Seasonality shines in April, which is the strongest month of the November-April period and is up 66% of the time with an average return of 1.37%,\" BofA said. The bank's seasonality analysis is based on data going back to 1928.\nOn top of that, April is the second best month behind July in terms of average return, and the second best month behind December in terms of the percentage of time up, according to BofA.\nFrom a technical perspective, BofA highlights big picture levels on the S&P 500, based on a bullish cup and handle pattern formed last year. A cup and handle often resembles a cup, formed by a basing pattern that typically looks like a \"U,\" followed by a handle that is formed by a short-term down trend. This pattern usually extends an uptrend that is already in place.\nBofA's 4,270 price target on the S&P 500 is based on a measured move of the depth of the cup formed in March of 2020 and the eventual breakout later in July.\nAlso favoring continued upside for the S&P 500 is new highs in Advance/Decline line, which indicates that underlying market breadth is strong. The Advance/Decline line measures the difference of stocks that are moving higher or lower on a daily basis.\n\"A bullish A-D line sets up the S&P 500 for a breakout above 3,950 - 3,960 that would favor upside to 4,065 next with the 2020 cup and handle target at 4,270,\" BofA said.\nAnd if the S&P 500 does falter, investors should look to big picture support levels at 3,700, 3,550, and 3,200, BofA highlighted.\nBank of America","news_type":1},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325469184,"gmtCreate":1615914546248,"gmtModify":1704788477085,"author":{"id":"3578379695086113","authorId":"3578379695086113","name":"Prospersim","avatar":"https://static.tigerbbs.com/6ed1a29580048152f8f7a90edcb6861b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325469184","repostId":"1121564086","repostType":4,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}